A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

Clinical trial NCT00670423 · COMPLETED

Trial details

NCT number: NCT00670423
Sponsor: Jennifer E. Schwartz
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Graft vs Host Disease Peripheral Blood Stem Cell Transplantation Transplantation, Homologous

Start date: 2008-05-16
Primary completion: 2012-07-05
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.